000172639 001__ 172639
000172639 005__ 20210129214455.0
000172639 0247_ $$2doi$$a10.1016/j.parkreldis.2014.09.021
000172639 0247_ $$2ISSN$$a1353-8020
000172639 0247_ $$2ISSN$$a1873-5126
000172639 0247_ $$2WOS$$aWOS:000347662000017
000172639 0247_ $$2altmetric$$aaltmetric:2745393
000172639 0247_ $$2pmid$$apmid:25282319
000172639 037__ $$aFZJ-2014-06096
000172639 082__ $$a610
000172639 1001_ $$0P:(DE-Juel1)131613$$aBarbe, Michael$$b0$$eCorresponding Author$$ufzj
000172639 245__ $$aUtilization of predefined stimulation groups by essential tremor patients treated with VIM-DBS
000172639 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2014
000172639 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1420463477_23891
000172639 3367_ $$2DataCite$$aOutput Types/Journal article
000172639 3367_ $$00$$2EndNote$$aJournal Article
000172639 3367_ $$2BibTeX$$aARTICLE
000172639 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000172639 3367_ $$2DRIVER$$aarticle
000172639 520__ $$aObjective: To identify the utilization and general acceptance of switching between predefined stimulation groups in essential tremor (ET) patients treated with deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) of the thalamus.MethodsThirty-eight patients treated with VIM-DBS completed a telephone survey. This was designed to identify the general utilization of patient controllers and the specific usage of stimulation groups.ResultsThirty-eight patients were interviewed via phone. More than half (21 of 38 patients, 55%) of all contacted ET patients were aware of the possibility of switching between pre-defined stimulation programs themselves. Again, more than half of these patients (13 of the 21 patients) switch between the different programs on a regular basis (8 monthly, 2 weekly, and 3 daily), mainly due to occurring side effects. Age did not differ between the group of patients switching between stimulation groups, and those who did not (65.38 years (±11.36) vs. 69.15 years (±9.92), p = 0.297).ConclusionSome patients frequently use different stimulation settings, mainly to be able to control side effects when necessary. All patients – independent of their age - and especially patients with stimulation induced side effects, should therefore be informed about the possibility to switch between predefined stimulation groups. We propose a training for patients by specialized nurses, to give them confidence in handling the patient controllers.
000172639 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000172639 536__ $$0G:(DE-HGF)POF2-89572$$a89572 - (Dys-)function and Plasticity (POF2-89572)$$cPOF2-89572$$fPOF II T$$x1
000172639 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000172639 7001_ $$0P:(DE-HGF)0$$aPochmann, Jil$$b1
000172639 7001_ $$0P:(DE-HGF)0$$aLewis, Catharine J.$$b2
000172639 7001_ $$0P:(DE-HGF)0$$aAllert, Niels$$b3
000172639 7001_ $$0P:(DE-HGF)0$$aWirths, Jochen$$b4
000172639 7001_ $$0P:(DE-HGF)0$$aVisser-Vandewalle, Veerle$$b5
000172639 7001_ $$0P:(DE-HGF)0$$aTimmermann, Lars$$b6
000172639 773__ $$0PERI:(DE-600)2027635-7$$a10.1016/j.parkreldis.2014.09.021$$gp. S1353802014003587$$n12$$p1415–1418$$tParkinsonism & related disorders$$v20$$x1353-8020$$y2014
000172639 8564_ $$uhttps://juser.fz-juelich.de/record/172639/files/FZJ-2014-06096.pdf$$yRestricted
000172639 909CO $$ooai:juser.fz-juelich.de:172639$$pVDB
000172639 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000172639 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000172639 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000172639 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000172639 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000172639 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000172639 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000172639 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000172639 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF <  5
000172639 9141_ $$y2014
000172639 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131613$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000172639 9132_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000172639 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000172639 9131_ $$0G:(DE-HGF)POF2-89572$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$v(Dys-)function and Plasticity$$x1
000172639 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000172639 980__ $$ajournal
000172639 980__ $$aVDB
000172639 980__ $$aI:(DE-Juel1)INM-3-20090406
000172639 980__ $$aUNRESTRICTED